Skip to main content
  • Book
  • © 2018

The Basics of Cancer Immunotherapy

  • Aimed specifically at cancer patients to serve as a resource when seeking immunotherapy as a treatment option
  • Detailed focus on various cancers provides disease-specific insights in applying immunotherapy to each disease
  • Provides direct clinical evidence based on clinical studies and observations to address the risks and benefits of cancer immunotherapy

Buy it now

Buying options

eBook USD 29.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 37.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (10 chapters)

  1. Front Matter

    Pages i-x
  2. Therapeutic Targets of FDA-Approved Immunotherapies in Oncology

    • Svetomir N. Markovic, Anagha Bangalore Kumar
    Pages 21-37
  3. Melanoma Immunotherapy

    • Matthew S. Block
    Pages 39-57
  4. Significance of Immune Checkpoints in Lung Cancer

    • Konstantinos Leventakos, Aaron S. Mansfield
    Pages 59-77
  5. Genitourinary Malignancies

    • Roxana Dronca, Anagha Bangalore Kumar
    Pages 79-94
  6. Immunotherapy for Other Malignancies

    • Yiyi Yan
    Pages 125-142
  7. Resources for Patients

    • Yiyi Yan
    Pages 153-154
  8. Back Matter

    Pages 155-160

About this book

This book provides patients and their physicians (especially “non-oncologist” health care providers) with a clear and concise introduction to cancer immunotherapy, which, unlike traditional forms of cancer therapy, acts by boosting the patient’s own immune system to fight cancer. The unique features of cancer immunotherapy make its management, monitoring and side-effects different from those of traditional cancer therapy. Especially novel are the side effects of cancer immunotherapy, necessitating greater awareness for both patients and physicians in order to minimize complications of therapy.   

The patient-friendly, concise, easy-to-understand, and up-to-date knowledge presented in this book will inform patients about the benefits and risks of cancer immunotherapy, and help them and their care providers to understand how immunotherapy would control their unique disease.   Researchers and academic professionals in the field of cancer immunotherapy will also find clear and usefulinformation to help them communicate with patients or address unresolved problems.  Some key features of the book are:

Expertise. All editors and authors are scientists and oncologists specializing in cancer immunotherapy, and are involved in scientific discovery from the early stage of immune-checkpoint inhibitors to today’s daily patient care. Their insights, expertise and experience guarantee the high quality and authority in the science, medicine and practice of cancer immunotherapy.

Patient-friendly. This book is written for cancer patients in order to meet their needs when considering immunotherapy. As an educational tool, this book will help the reader balance the risks and benefits based on both science and clinical facts, and therefore to make the best choice in receiving or withdrawing from immunotherapy.

Disease Specificity. Cancer is a complicated disease involving multiple stages and pathology.Its response to immunotherapy is individualized and varies depending on cancer types. The authors’ expertise in treating different types of cancers, including melanoma, lung, kidney,  bladder, and lymphoma, provides disease-specific insights in applying immunotherapy to each disease.

Editors and Affiliations

  • Department of Urology, Department of Immunology, College of Medicine, Mayo Clinic, Rochester, USA

    Haidong Dong

  • Department of Oncology, Department of Medicine/Division of Hematology, Department of Immunology, College of Medicine, Mayo Clinic, Rochester, USA

    Svetomir N. Markovic

About the editors

Haidong Dong is a tumor immunologist who co-discovered B7-H1 (PD-L1) in 1998 at the Mayo Clinic, USA. His research is on mechanisms of cancer immunity and developments of cancer immunotherapy.

Svetomir Markovic is a medical oncologist and physician scientist at the Mayo Clinic who specializes in the care of patients with metastatic melanoma. His research is focused on melanoma immune biology and immunotherapy.   

Bibliographic Information

  • Book Title: The Basics of Cancer Immunotherapy

  • Editors: Haidong Dong, Svetomir N. Markovic

  • DOI: https://doi.org/10.1007/978-3-319-70622-1

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer International Publishing AG 2018

  • Softcover ISBN: 978-3-319-70621-4Published: 12 January 2018

  • eBook ISBN: 978-3-319-70622-1Published: 05 January 2018

  • Edition Number: 1

  • Number of Pages: X, 160

  • Number of Illustrations: 4 b/w illustrations, 4 illustrations in colour

  • Topics: Popular Science in Medicine and Health, Immunology, Cancer Research

Buy it now

Buying options

eBook USD 29.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 37.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access